Patents by Inventor Imtiaz Chaudry

Imtiaz Chaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
    Publication number: 20030124063
    Abstract: The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.
    Type: Application
    Filed: December 28, 2001
    Publication date: July 3, 2003
    Inventors: Imtiaz Chaudry, Partha Banerjee
  • Formoterol/steroid bronchodilating compositions and methods of use thereof
    Publication number: 20030055026
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchocon-strictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: June 22, 2001
    Publication date: March 20, 2003
    Applicant: Dey L.P.
    Inventors: Partha S. Banerjee, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Patent number: 6514520
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: February 4, 2003
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Non-chlorofluorocarbon aerosol formulations
    Patent number: 6503482
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons, for oral and/or nasal administration, are described. The formulations comprise 1,1,1,2-tetrafluoroethane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment using the formulations also are described.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: January 7, 2003
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Formoterol/steroid bronchodilating compositions and methods of use thereof
    Publication number: 20020183293
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: May 13, 2002
    Publication date: December 5, 2002
    Inventors: Partha S. Banerjee, Imtiaz A. Chaudry
  • Bronchodilating compositions and methods
    Publication number: 20020151597
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: June 22, 2001
    Publication date: October 17, 2002
    Applicant: Dey L.P.
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Bronchodilating compositions and methods
    Publication number: 20020151598
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: May 3, 2002
    Publication date: October 17, 2002
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Publication number: 20020132805
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: July 5, 2001
    Publication date: September 19, 2002
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20020127187
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 12, 2002
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20020103175
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: August 1, 2002
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Aerosol formulations of albuterol and 1,1,1,2-tetrafluoroethane
    Patent number: 6416743
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons, for oral and/or nasal administration are described. The formulations comprise 1,1,1,2 tetrafluoroethane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations also are described.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: July 9, 2002
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6365581
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: April 2, 2002
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Orally administrable solid ribavirin dosage forms and process for making them
    Patent number: 6337090
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: January 8, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Orally administrable solid dosage form
    Patent number: 6335032
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: January 1, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Mometasone furoate suspensions for nebulization
    Patent number: 6187765
    Abstract: An aqueous nebulizer suspension contains water, mometasone furoate monohydrate, a nonionic surfactant, a soluble salt and optionally a pH buffer. The suspension may be prepared by ultrasonication or jet milling techniques.
    Type: Grant
    Filed: October 6, 1998
    Date of Patent: February 13, 2001
    Assignee: Schering Corporation
    Inventors: David Harris, Joel A. Sequeira, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Patent number: 6132758
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: October 17, 2000
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Chlorofluorocarbon-free mometasone furoate aerosol formulations
    Patent number: 6068832
    Abstract: The invention relates to suspension aerosol formulations which exhibit stable particle sizes, containing mometasone furoate, about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3,3-Heptafluoropropane as the propellant. A surfactant, such as oleic acid, can also be included. These formulations are suitable for use in metered dose inhalers.
    Type: Grant
    Filed: August 27, 1997
    Date of Patent: May 30, 2000
    Assignee: Schering Corporation
    Inventors: Julianne Berry, Joel A. Sequeira, Imtiaz A. Chaudry
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6057307
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: May 2, 2000
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Orally administrable solid dosage form
    Patent number: 6051252
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is subsantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: April 18, 2000
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Process of making solid ribavirin dosage forms
    Patent number: 5916594
    Abstract: A process of making an orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin as determined is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 29, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen